Royal Bank of Canada’s Mersana Therapeutics MRSN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$0 Sell
6
-59
-91% ﹤0.01% 6776
2025
Q1
$0 Sell
65
-295
-82% ﹤0.01% 6574
2024
Q4
$12K Sell
360
-98
-21% -$3.27K ﹤0.01% 5800
2024
Q3
$22K Buy
458
+31
+7% +$1.49K ﹤0.01% 5608
2024
Q2
$21K Buy
427
+325
+319% +$16K ﹤0.01% 5666
2024
Q1
$11K Sell
102
-1,293
-93% -$139K ﹤0.01% 5723
2023
Q4
$81K Buy
1,395
+798
+134% +$46.3K ﹤0.01% 5207
2023
Q3
$19K Buy
597
+82
+16% +$2.61K ﹤0.01% 5707
2023
Q2
$42K Buy
515
+306
+146% +$25K ﹤0.01% 5409
2023
Q1
$21K Sell
209
-318
-60% -$32K ﹤0.01% 5625
2022
Q4
$76K Buy
527
+415
+371% +$59.8K ﹤0.01% 5179
2022
Q3
$18K Buy
112
+92
+460% +$14.8K ﹤0.01% 5697
2022
Q2
$2K Sell
20
-156
-89% -$15.6K ﹤0.01% 6504
2022
Q1
$18K Sell
176
-428
-71% -$43.8K ﹤0.01% 6171
2021
Q4
$94K Buy
604
+326
+117% +$50.7K ﹤0.01% 5466
2021
Q3
$66K Buy
278
+89
+47% +$21.1K ﹤0.01% 5478
2021
Q2
$64K Buy
189
+29
+18% +$9.82K ﹤0.01% 5381
2021
Q1
$65K Buy
160
+143
+841% +$58.1K ﹤0.01% 5234
2020
Q4
$11K Buy
17
+13
+325% +$8.41K ﹤0.01% 5780
2020
Q3
$2K Hold
4
﹤0.01% 5830
2020
Q2
$3K Sell
4
-2
-33% -$1.5K ﹤0.01% 5714
2020
Q1
$1K Sell
6
-125
-95% -$20.8K ﹤0.01% 5957
2019
Q4
$19K Buy
131
+106
+424% +$15.4K ﹤0.01% 5271
2019
Q3
$1K Sell
25
-38
-60% -$1.52K ﹤0.01% 5805
2019
Q2
$6K Buy
+63
New +$6K ﹤0.01% 5342
2018
Q4
Sell
-10
Closed -$2K 6000
2018
Q3
$2K Buy
10
+4
+67% +$800 ﹤0.01% 5913
2018
Q2
$3K Buy
+6
New +$3K ﹤0.01% 5583
2018
Q1
Sell
-2
Closed -$1K 5866
2017
Q4
$1K Sell
2
-12
-86% -$6K ﹤0.01% 5641
2017
Q3
$6K Buy
+14
New +$6K ﹤0.01% 5633